Who Paid My Doc Search
Menu
Organisation paid for research Program year 2024 Source: CMS Open Payments

Akdhc LLC

Neither a doctor nor a teaching hospital

Research payments

$26,136

5 payments

Through program year 2024, Akdhc LLC is reported as receiving $26,136 in research payments, across 5 payments.

By program year

3 rows
Year Kind Amount Payments
2024 Research $17,160 2
2023 Research $7,726 1
2022 Research $1,250 2

Breakdown

Who paid Research payments · program years 2022–2024
  1. Biogen, Inc. $17,160 2 payments
  2. Boehringer Ingelheim Pharmaceuticals, Inc. $8,950 2 payments
  3. Boehringer Ingelheim International GmbH $26 1 payment
Studies the money was for Research payments · program years 2022–2024
  1. A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON (FALCON) $9,692 1 payment
  2. Phase II dose finding PoCC in CKD $8,976 3 payments
  3. An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) (EAGLE) $7,469 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record